Split thickness skin grafting in dermatosurgery: A prospective rednomised study to compare the donorsites scalp vs. thigh

Split thickness skin grafting in dermatosurgery: A prospective rednomised study to compare the donorsites scalp vs. thigh - HAUTTRANS_01

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00006775

Enrollment

100

Registered

2015-02-04

Start date

2014-01-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C44.3

Interventions

Group 1: Patients with occipital donor site of split thickness skin graft Group 2: Patients with femoral donor site splith thickness skin graft

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: wounds after micrographic controlled tumorsurgery on the head and face area (group 1) and extremities and body (group 2) - age 18+ - Capacity for consent

Exclusion criteria

Exclusion criteria: Pregnancy Alopecia at possible donorsite inflammation/infection at possible donorsite skin atrophy at possible donorsite scar at possible donorsite disease of immunsystem immunsupressive medication

Design outcomes

Primary

Measure	Time frame
Reepithelialization (in%) at the donor sites the diagnostic assessment on the 7th postoperative day	—

Secondary

Measure	Time frame
- Quantitative determination of reepithelialization on all days of the survey expect of day 7 - Quantitative determination of the maximum healing rate at the aceptor site - Detection of patient satisfaction - Recognition of pain intensity (visual analogue scale (VAS)) to donor site and recipient site - Quantitative evaluation in accordance Vancouver Scare Scale - Qualitative evaluation of the donor site (alopecia) - Qualitative evaluation of graft shrinking - Cosmetic outcome - Complications	—

Measure

Time frame

- Quantitative determination of reepithelialization on all days of the survey expect of day 7 - Quantitative determination of the maximum healing rate at the aceptor site - Detection of patient satisfaction - Recognition of pain intensity (visual analogue scale (VAS)) to donor site and recipient site - Quantitative evaluation in accordance Vancouver Scare Scale - Qualitative evaluation of the donor site (alopecia) - Qualitative evaluation of graft shrinking - Cosmetic outcome - Complications

—

Countries

Germany

Contacts

Public ContactMaximilian Kovacs

Klinikum Darmstadt- Hautklinik

hautklinik@klinikum-darmstadt.de06151-1074160

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026